TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03279016 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05140707 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02237625 — Predictive Biomarker (PRD): ALPL mRNA
Genes: ALPL
Study NCT04380207 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT03184597 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT03184597 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT03184597 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study NCT04240600 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04240600 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00011011 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01176565 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01737294 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study NCT05332808 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04375267 — Predictive Biomarker (PRD): SSB mRNA
Genes: SSB
Study NCT01208233 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02145897 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02145897 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02145897 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01131741 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00797615 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03145272 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03145272 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03734198 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03734198 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT03734198 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT03734198 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT03734198 — Predictive Biomarker (PRD): ZAP70 mRNA
Genes: ZAP70; SRK
Study NCT03017313 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT01839383 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT01839383 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01839383 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT01202409 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00858247 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00951964 — Predictive Biomarker (PRD): COL7A1 mRNA
Genes: COL7A1
Study NCT03500588 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03500588 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06664255 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00539487 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02880332 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT01975142 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02296203 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02296203 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT00321321 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02022241 — Surrogate Endpoint (SUR): Serum luteinizing hormone
Study NCT00313547 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01179061 — Predictive Biomarker (PRD): APLNR mRNA
Genes: APLNR; AGTRL1; APJ
Study NCT03175224 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03175224 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT03175224 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00947297 — Predictive Biomarker (PRD): HPN mRNA
Genes: HPN; TMPRSS1
Study NCT01654185 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00864474 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT02851108 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT03483233 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT00001368 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03337087 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT03337087 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT01507493 — Predictive Biomarker (PRD): SCN9A mRNA
Genes: SCN9A; NENA
Study NCT02056210 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02923609 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00827372 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00403481 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03836742 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study NCT01013506 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01123473 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01123473 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04255745 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04472988 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT00536146 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00536146 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT03120299 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02815137 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01050387 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT02649972 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT04402827 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04402827 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04402827 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04405076 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02142881 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00151788 — Predictive Biomarker (PRD): ACAT1 mRNA
Genes: ACAT1; ACAT; MAT
Study NCT01579396 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01579396 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT00820924 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01813981 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT04287660 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04828655 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00279708 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00279708 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00279708 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT04683445 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04683445 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02326766 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT02326766 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00955149 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00955149 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05236309 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03082794 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03082794 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00982111 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00982111 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04254029 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00487448 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04082377 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04082377 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00948610 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00005761 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00005761 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02331446 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02331446 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02322190 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT02322190 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study NCT02322190 — Predictive Biomarker (PRD): TNFRSF1A mRNA
Genes: TNFRSF1A; TNFAR; TNFR1
Study NCT02350855 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT01500824 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01663259 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01663259 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00741702 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02642965 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01564953 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00553007 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01395277 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04040842 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study NCT04000425 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00804427 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03205696 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01748123 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02641522 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT03976284 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00404326 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00001453 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT00001453 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT00182949 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03892538 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01038778 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02041312 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03615391 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00328497 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00328497 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03444142 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04560894 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT01251484 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04295889 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04600960 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT01665599 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01187147 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT03950557 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04032080 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04791800 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02442817 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT02442817 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03891485 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT00733824 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00733824 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01248117 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01218139 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02975752 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02975752 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02772978 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT02068560 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02872818 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study NCT01228240 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03097068 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04119206 — Surrogate Endpoint (SUR): Serum sodium
Study NCT04537715 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06064123 — Predictive Biomarker (PRD): EMB mRNA
Genes: EMB
Study NCT06064123 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03274804 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT02411786 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02411786 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02210013 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01531972 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT01531972 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT03055390 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT01294995 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01294995 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00259857 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05684666 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01384383 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT04390412 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01019499 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04094714 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02228096 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03574506 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT02526992 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04276974 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00421642 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01995149 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT01698411 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00140959 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01403103 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT04341181 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT03380039 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT01162668 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00701597 — Predictive Biomarker (PRD): EDNRA mRNA
Genes: EDNRA; ETA; ETRA
Study NCT00701597 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT00427804 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01984749 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00513058 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04103125 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02972905 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00349622 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02151643 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT01709123 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01709123 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04514705 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01399008 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT03299660 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04016350 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT04430556 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04722068 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study NCT02413801 — Predictive Biomarker (PRD): TTLL5 mRNA
Genes: TTLL5; KIAA0998; STAMP
Study NCT00359450 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00359450 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00359450 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03412383 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02909322 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02233049 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02233049 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04904523 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03529110 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04051450 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04051450 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04966923 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01547091 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02054884 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT04081272 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT00188773 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00188773 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01585051 — Predictive Biomarker (PRD): HBA1 mRNA
Genes: HBA1; HBA2
Study NCT01585051 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01850238 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03390907 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT02560246 — Predictive Biomarker (PRD): SPTB mRNA
Genes: SPTB; SPTB1
Study NCT02526381 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT05369702 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT03731260 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT00012376 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01731067 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT01731067 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT01731067 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01731067 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01731067 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00547950 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03062800 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00708383 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02431676 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study NCT04056780 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04056780 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04056780 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02805647 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT01007461 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study NCT00445614 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00491920 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03003520 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04385212 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04489121 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT01269255 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00176475 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03412604 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02191839 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT02191839 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04570254 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study NCT02482402 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT01013363 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00322894 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01470664 — Predictive Biomarker (PRD): FST mRNA
Genes: FST
Study NCT02801890 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04637919 — Surrogate Endpoint (SUR): Neutralizing antibody